Trial Profile
Prospective and Non-interventional registry to Investigate Effectiveness and Safety of Rivaroxaban on Prevention of Stroke and Systemic Embolism in Patients with Non-valvular Atrial Fibrillation at Fukui Red Cross Hospital
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 May 2015
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Embolism; Stroke
- Focus Therapeutic Use
- 14 May 2015 New trial record